326 related articles for article (PubMed ID: 23529258)
1. Epigenetic alterations and their clinical implications in esophageal squamous cell carcinoma.
Toh Y; Egashira A; Yamamoto M
Gen Thorac Cardiovasc Surg; 2013 May; 61(5):262-9. PubMed ID: 23529258
[TBL] [Abstract][Full Text] [Related]
2. Abnormal histone acetylation and methylation levels in esophageal squamous cell carcinomas.
Chen C; Zhao M; Yin N; He B; Wang B; Yuan Y; Yu F; Hu J; Yin B; Lu Q
Cancer Invest; 2011 Oct; 29(8):548-56. PubMed ID: 21843048
[TBL] [Abstract][Full Text] [Related]
3. Review of the alterations in DNA methylation in esophageal squamous cell carcinoma.
Baba Y; Watanabe M; Baba H
Surg Today; 2013 Dec; 43(12):1355-64. PubMed ID: 23291904
[TBL] [Abstract][Full Text] [Related]
4. Comparative analysis of histone H3 and H4 post-translational modifications of esophageal squamous cell carcinoma with different invasive capabilities.
Zhang K; Li L; Zhu M; Wang G; Xie J; Zhao Y; Fan E; Xu L; Li E
J Proteomics; 2015 Jan; 112():180-9. PubMed ID: 25234497
[TBL] [Abstract][Full Text] [Related]
5. H3K9me3, H3K36me3, and H4K20me3 Expression Correlates with Patient Outcome in Esophageal Squamous Cell Carcinoma as Epigenetic Markers.
Zhou M; Li Y; Lin S; Chen Y; Qian Y; Zhao Z; Fan H
Dig Dis Sci; 2019 Aug; 64(8):2147-2157. PubMed ID: 30788686
[TBL] [Abstract][Full Text] [Related]
6.
Gonzaga IM; Soares Lima SC; Nicolau MC; Nicolau-Neto P; da Costa NM; de Almeida Simão T; Hernandez-Vargas H; Herceg Z; Ribeiro Pinto LF
Clin Epigenetics; 2017; 9():130. PubMed ID: 29296124
[TBL] [Abstract][Full Text] [Related]
7. Promoter methylation of tumor suppressor genes in esophageal squamous cell carcinoma.
Li JS; Ying JM; Wang XW; Wang ZH; Tao Q; Li LL
Chin J Cancer; 2013 Jan; 32(1):3-11. PubMed ID: 22572016
[TBL] [Abstract][Full Text] [Related]
8. Esophageal squamous cell carcinoma (ESCC): advance in genomics and molecular genetics.
Chen J; Kwong DL; Cao T; Hu Q; Zhang L; Ming X; Chen J; Fu L; Guan X
Dis Esophagus; 2015 Jan; 28(1):84-9. PubMed ID: 23796192
[TBL] [Abstract][Full Text] [Related]
9. Identification of PTK6, via RNA sequencing analysis, as a suppressor of esophageal squamous cell carcinoma.
Ma S; Bao JYJ; Kwan PS; Chan YP; Tong CM; Fu L; Zhang N; Tong AHY; Qin YR; Tsao SW; Chan KW; Lok S; Guan XY
Gastroenterology; 2012 Sep; 143(3):675-686.e12. PubMed ID: 22705009
[TBL] [Abstract][Full Text] [Related]
10. DNMT1-microRNA126 epigenetic circuit contributes to esophageal squamous cell carcinoma growth via ADAM9-EGFR-AKT signaling.
Liu R; Gu J; Jiang P; Zheng Y; Liu X; Jiang X; Huang E; Xiong S; Xu F; Liu G; Ge D; Chu Y
Clin Cancer Res; 2015 Feb; 21(4):854-63. PubMed ID: 25512445
[TBL] [Abstract][Full Text] [Related]
11. Aberrant methylation and decreased expression of the TGF-β/Smad target gene FBXO32 in esophageal squamous cell carcinoma.
Guo W; Zhang M; Shen S; Guo Y; Kuang G; Yang Z; Dong Z
Cancer; 2014 Aug; 120(16):2412-23. PubMed ID: 24798237
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic inactivation of secreted frizzled-related protein 2 in esophageal squamous cell carcinoma.
Hao XW; Zhu ST; He YL; Li P; Wang YJ; Zhang ST
World J Gastroenterol; 2012 Feb; 18(6):532-40. PubMed ID: 22363119
[TBL] [Abstract][Full Text] [Related]
13. Methylation-mediated repression of potential tumor suppressor miR-203a and miR-203b contributes to esophageal squamous cell carcinoma development.
Liu Y; Dong Z; Liang J; Guo Y; Guo X; Shen S; Kuang G; Guo W
Tumour Biol; 2016 Apr; 37(4):5621-32. PubMed ID: 26577858
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic inactivation of the SFRP1 gene in esophageal squamous cell carcinoma.
Meng Y; Wang QG; Wang JX; Zhu ST; Jiao Y; Li P; Zhang ST
Dig Dis Sci; 2011 Nov; 56(11):3195-203. PubMed ID: 21567192
[TBL] [Abstract][Full Text] [Related]
15. Identification of novel molecular targets regulated by tumor suppressive miR-375 induced by histone acetylation in esophageal squamous cell carcinoma.
Isozaki Y; Hoshino I; Nohata N; Kinoshita T; Akutsu Y; Hanari N; Mori M; Yoneyama Y; Akanuma N; Takeshita N; Maruyama T; Seki N; Nishino N; Yoshida M; Matsubara H
Int J Oncol; 2012 Sep; 41(3):985-94. PubMed ID: 22752059
[TBL] [Abstract][Full Text] [Related]
16. Elevated expression of MDR1 associated with Line-1 hypomethylation in esophageal squamous cell carcinoma.
Zhu J; Ling Y; Xu Y; Lu MZ; Liu YP; Zhang CS
Int J Clin Exp Pathol; 2015; 8(11):14392-400. PubMed ID: 26823755
[TBL] [Abstract][Full Text] [Related]
17. H3K27 acetylation activated-long non-coding RNA CCAT1 affects cell proliferation and migration by regulating SPRY4 and HOXB13 expression in esophageal squamous cell carcinoma.
Zhang E; Han L; Yin D; He X; Hong L; Si X; Qiu M; Xu T; De W; Xu L; Shu Y; Chen J
Nucleic Acids Res; 2017 Apr; 45(6):3086-3101. PubMed ID: 27956498
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic changes within the promoter regions of antigen processing machinery family genes in Kazakh primary esophageal squamous cell carcinoma.
Sheyhidin I; Hasim A; Zheng F; Ma H
Asian Pac J Cancer Prev; 2014; 15(23):10299-306. PubMed ID: 25556465
[TBL] [Abstract][Full Text] [Related]
19. Network-based analysis identifies epigenetic biomarkers of esophageal squamous cell carcinoma progression.
Cheng CP; Kuo IY; Alakus H; Frazer KA; Harismendy O; Wang YC; Tseng VS
Bioinformatics; 2014 Nov; 30(21):3054-61. PubMed ID: 25015989
[TBL] [Abstract][Full Text] [Related]
20. Genomic and Epigenomic Aberrations in Esophageal Squamous Cell Carcinoma and Implications for Patients.
Lin DC; Wang MR; Koeffler HP
Gastroenterology; 2018 Jan; 154(2):374-389. PubMed ID: 28757263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
